Cheap Generic Drugs May Not Be Safe for US Troops - Bloomberg
4.7 (446) · € 32.50 · Auf Lager
The US drug-safety regulator has resisted independent testing that’s widely used in Europe.
The Innovator's Prescription: A Disruptive Solution for Health
Ozempic Could Be The Next Target of Medicare Price Negotiations
Drugmakers Tap Big Law Attorneys to Fight Medicare Price Program
The Dangers of Unregulated Drug Ads, Johns Hopkins
Why Are Generic Drugs Hard to Find? Because They're Not Profitable
Forces influencing generic drug development in the United States
Ozempic Mania's Billions in Bills Are Coming for US Taxpayers
Worth the price? Push for cheaper generic drugs has Canadians
HIV Drug Prices in Brazil: Expensive Due to Lack of Generic Drugs
Are Pharmacy Benefit Managers to Blame for the High Cost of
Secret White House Team Tackles Drug Shortages, Quality Woes (1)
U.S. government to buy $1 billion more worth of Merck's COVID-19